| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 06/20/2002 | WO2002048129A1 Method for the hydrogenation of maleic anhydride and related compounds in two serial reaction zones |
| 06/20/2002 | WO2002048128A2 Method for the production of tetrahydrofuran |
| 06/20/2002 | WO2002048124A2 Piperazine derivatives |
| 06/20/2002 | WO2002048100A2 Thiosulphonic s-esters as material protective agent |
| 06/20/2002 | WO2002048092A2 Compounds for altering mitochondrial function and cellular responses |
| 06/20/2002 | WO2002048085A1 Process for producing product of decomposition of fluorinated ester compound |
| 06/20/2002 | WO2002048078A1 2-butyl-3-(4-[3(dibutylamino)propoxy]benzoyl)-5-nitro-benzofuran hydrochloride and preparation thereof |
| 06/20/2002 | WO2002047818A1 Porous catalyst for the hydrogenation of maleic anhydride to tetrahydrofuran |
| 06/20/2002 | WO2002047815A1 CATALYTIC COATING FOR THE HYDROGENATION OF MALEIC ANHYDRIDE AND RELATED COMPOUNDS TO GIVE η-BUTYROLACTONE, TETRAHYDROFURAN AND DERIVATIVES THEREOF |
| 06/20/2002 | WO2002047762A1 Serine protease inhibitors |
| 06/20/2002 | WO2002018316A3 Two-stage process for the hydrogenation of maleic acid to 1,4-butanediol |
| 06/20/2002 | WO2002012214A3 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
| 06/20/2002 | WO2001094543A3 Production and use of derivatized homoserine lactones |
| 06/20/2002 | US20020077489 Process for preparing mint lactone |
| 06/20/2002 | US20020077455 Protease inhibitors |
| 06/20/2002 | US20020077356 Nonsteroidal antiinflammatory agents |
| 06/20/2002 | US20020077353 Reacting 1-(3-Dimethylamino-1-propyl)-1-(4-fluorophenyl)-5-((trifluoromethyl)sulfonyl-oxy)-1,3-dihydroisobenzofurane or 1-(4'-fluorophenyl)-1- (3-dimethylaminopropyl)-5-bromophtalane with with a cyanide source in presence of palladium catalyst |
| 06/20/2002 | US20020077352 N-methyl-D-aspartate receptor antagonists |
| 06/20/2002 | US20020077347 For therapy of diabetes, obesity |
| 06/20/2002 | US20020077343 H2 receptor antagonist compounds in combination with nitric oxide donors, compostions and methods of use |
| 06/20/2002 | US20020077320 For use as hypolipidemic, antihyperglycemic compounds |
| 06/20/2002 | US20020077316 For therapy and prophylaxis of cardiovascular disease, dyslipidemia; dyslipoproteinemia; disorder of glucose metabolism; Alzheimer's Disease; Syndrome X; peroxisome proliferator activated receptor-associated disorder |
| 06/20/2002 | DE10061876A1 Arylierte Furan- und Thiophencarbonsäureamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen Arylated furan and thiophenecarboxamides, processes for their preparation, their use as a medicine and pharmaceutical compositions containing them |
| 06/20/2002 | DE10061555A1 Schalenkatalysator für die Hydrierung von Maleinsäureanhydrid und verwandten Verbindungen zu gamma-Butyrolacton und Tetrahydrofuran und Derivaten davon A coated catalyst for the hydrogenation of maleic anhydride and related compounds to tetrahydrofuran and gamma-butyrolactone and derivatives thereof |
| 06/20/2002 | DE10060809A1 Substituierte Anthranilsäuren, ihre Verwendung als Medikament oder Diagnostikum, sowie sie enthaltendes Medikament, sowie ein pharmazeutisches Kombinationspräparat mit einem Natrium/Wasserstoff-Austausch (NHE)-Blocker Substituted anthranilic acids, their use as a medicament or diagnostic, and she containing drug, as well as a pharmaceutical combination preparation with a sodium / hydrogen exchange (NHE) blockers |
| 06/20/2002 | CA2431095A1 Arylated furan- and thiophenecarboxamides, with potassium channel-blocking action |
| 06/20/2002 | CA2429352A1 Antiviral agents for treatment of flaviviridae infections |
| 06/19/2002 | EP1215210A2 Benzofurans |
| 06/19/2002 | EP1215203A1 Hydroxamic acid derivatives, process for the production thereof and drugs containing the same as the active ingredient |
| 06/19/2002 | EP1215201A2 Process for the preparation of aryloctanoyl amides |
| 06/19/2002 | EP1214944A1 Percutaneous absorption agents |
| 06/19/2002 | EP1214316A1 Five membered-ring compounds and utilization thereof in liquid crystal mixtures |
| 06/19/2002 | EP1214306A1 Liquid crystal compounds |
| 06/19/2002 | EP1214301A1 Hypoglycemic n,n-arylsulfonylglycine compounds |
| 06/19/2002 | EP1214292A1 Tyrosine derivatives |
| 06/19/2002 | EP1213975A2 Method for extracting compounds of furan lipids and polyhydroxylated fatty alcohols of avocado, composition based on said compounds, and therapeutic, cosmetical or food use of said compounds |
| 06/19/2002 | CN1354622A Prostaglandin compound, compositions and methods of treating peripheral vascular disease and pulmonary hypertension |
| 06/19/2002 | CN1354165A Control of waste water produced in furfural industry and preparation process of butyl acetate |
| 06/18/2002 | US6407267 Method for the preparation of citalopram |
| 06/18/2002 | US6407263 Preparation of sulfo-N-hydroxy succinimide salts |
| 06/18/2002 | US6407249 Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing a substituted phenylenediamine group |
| 06/18/2002 | US6407243 Postmemopause diseases |
| 06/18/2002 | US6407123 Diaminopyridine-containing thiourea inhibitors of herpes viruses |
| 06/18/2002 | US6407100 Fungicidal aromatic oximes |
| 06/18/2002 | US6407097 Pesticides, fungicides, and bactericides |
| 06/18/2002 | US6407030 Method for producing catalysts for synthesizing maleic anhydride by means of gas phase oxidation |
| 06/14/2002 | WO2001044187A1 Novel substituted tricyclic compounds |
| 06/14/2002 | WO2001041709A2 Methods for treating cell death diseases and inflammation |
| 06/14/2002 | CA2394778A1 Novel substituted tricyclic compounds |
| 06/14/2002 | CA2393722A1 Methods for treating cell death diseases and inflammation |
| 06/13/2002 | WO2002046240A1 Multicomponent compositions containing chitosan and methods of preparing same |
| 06/13/2002 | WO2002046179A1 (meth)acrylate esters, starting alcohols for the preparation thereof, processes for preparing both, polymers of the esters, chemically amplifiable resist compositions, and method for forming patterns |
| 06/13/2002 | WO2002046178A2 Benzofuran and benzothiophene derivatives as selective cox-2 inhibitors |
| 06/13/2002 | WO2002046155A1 Synthesis of fused pyrrolecarboxamides |
| 06/13/2002 | WO2002046148A1 Substituted anthranilic acids |
| 06/13/2002 | WO2002046130A1 Processes for electrically activated transformation of chemical and material compositions |
| 06/13/2002 | WO2002046129A2 Inhibitors of histone deacetylase |
| 06/13/2002 | WO2002004404A3 7,8 and 9-substituted tetracycline compounds |
| 06/13/2002 | WO2001083438A3 New gamma selective retinoids |
| 06/13/2002 | US20020072529 For therapy and prophylaxis of cerebral apoplexy and craniocerebral trauma |
| 06/13/2002 | US20020071857 Rapidly disintegrating oral formulation of a cyclooxygenase-2 inhibitor |
| 06/13/2002 | DE10061558A1 Verfahren zur Hydrierung von Maleinsäureanhydrid und verwandten Verbindungen in einem Wirbelschichtreaktor A process for the hydrogenation of maleic anhydride and related compounds in a fluidized bed reactor |
| 06/13/2002 | DE10061557A1 Verfahren zur Hydrierung von Maleinsäureanhydrid und verwandten Verbindungen in zwei hintereinandergeschalteten Reaktionszonen A process for the hydrogenation of maleic anhydride and related compounds in two successive reaction zones |
| 06/13/2002 | DE10061556A1 Verfahren zur Herstellung von Tetrahydrofuran A process for the production of tetrahydrofuran |
| 06/13/2002 | DE10061553A1 Poröser Katalysator für die Hydrierung von Maleinsäureanhydrid zu Tetrahydrofuran Porous catalyst for the hydrogenation of maleic anhydride to tetrahydrofuran |
| 06/13/2002 | DE10059864A1 Substituierte Amino-furan-2-yl-essigsäure- und Amino-thien-2-yl-essigsäure-Derivate Substituted amino-furan-2-yl-acetic acid and amino-thien-2-yl-acetic acid derivatives |
| 06/13/2002 | CA2437048A1 Benzofuran and benzothiophene derivatives as selective cox-2 inhibitors |
| 06/13/2002 | CA2436870A1 Substituted anthranilic acids |
| 06/13/2002 | CA2430841A1 Synthesis of fused pyrrolecarboxamides |
| 06/13/2002 | CA2426988A1 Multicomponent compositions containing chitosan and methods of preparing same |
| 06/12/2002 | EP1212310A1 Production of maleic anhydride |
| 06/12/2002 | EP1212302A1 Compounds and pharmaceutical compositions as cathepsin s inhibitors |
| 06/12/2002 | EP1032571B1 Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists |
| 06/12/2002 | EP0984778B1 Neuropeptide-y ligands |
| 06/12/2002 | EP0966437B1 5-aroylnaphthalene derivatives |
| 06/12/2002 | EP0966416B1 A process for the production of tetrahydrofuran, gammabutyrolactone and butanediol |
| 06/12/2002 | EP0885210B1 Tricylic compounds having binding affinity for melatonin receptors, their production and use |
| 06/12/2002 | EP0751939B1 Naphthylamides as central nervous system agents |
| 06/12/2002 | EP0746552B1 Tetrahydrofurans and tetrahydropyrans |
| 06/12/2002 | CN1353716A benzopyrans annelated in C7-C8 with an aromatic heterocycle and compositions and (co) polymer matrices containing them |
| 06/12/2002 | CN1353691A Cell adhesion-inhibiting anti inflammatory and immune-suppresive compounds |
| 06/12/2002 | CN1353627A Vanadium/phosphorus mixed oxide catalyst precursor |
| 06/11/2002 | US6403824 Process for the preparation for 4,5-diamino shikimic acid derivatives |
| 06/11/2002 | US6403814 Method for synthesizing diaryl-substituted heterocyclic compounds, including tetrahydrofurans |
| 06/11/2002 | US6403813 Reacting terephthalic acid with paraformaldehyde in oleum |
| 06/11/2002 | US6403799 Methods for the preparation of intermediates in the synthesis of HIV-protease inhibitors |
| 06/11/2002 | US6403644 For prevention and/or treatment of diseases induced by overexpression and excess activity of matrix metalloproteinase; for example, rheumatoid, arthrosteitis, unusual bone resorption, osteoporosis, periodontitis |
| 06/11/2002 | US6403639 2,3-dihydrobenzofuran derivatives |
| 06/11/2002 | US6403617 Including human cytomegalovirus, herpes simplex viruses, epstein-barr virus, varicella-zoster virus, humanherpesviruses-6 and -7, and kaposi herpesvirus |
| 06/11/2002 | US6403587 Autoimmune diseases, acute and chronic inflammatory conditions, allergic conditions, infection associated with inflammation, viral, transplantation tissue rejection, atherosclerosis, restenosis, hiv infectivity, and |
| 06/11/2002 | US6403585 α-and β-amino acid hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors |
| 06/06/2002 | WO2002044171A1 Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain |
| 06/06/2002 | US20020068832 Methods for making 2-(omega-alkoxycarbonylalkanoyl) -4-butanolide, ester of omega-hydroxy - ( omega-3 ) -ketoaliphatic acid, and derivatives thereof |
| 06/06/2002 | US20020068765 8,9-dihydro-7H-benzocycloheptene derivatives are useful for phophylaxis and therapy of osteoporosis(have selective estrogenic activity on bones) |
| 06/06/2002 | CA2430280A1 Substituted amino-furan-2-yl-acetic acid and amino-thien-2-yl-acetic acid derivatives and their use in the treatment of migraine and pain |
| 06/05/2002 | EP1211301A1 Organic electroluminescent device |
| 06/05/2002 | EP1210941A2 Pharmaceutical compositions containing ritonavir (ABT-538) in combination with indinavir (MK-639) and their use for treating AIDS |
| 06/05/2002 | EP1210333A2 Novel herbicides |
| 06/05/2002 | EP1210327A2 New vitamin d derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments |
| 06/05/2002 | EP1210326A2 Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors |